Companies similar to AbbVie (ABBV)
Health Care
AbbVie (ABBV)'s closest peers include Johnson & Johnson (JNJ), Amgen (AMGN), Lilly (Eli) (LLY), Pfizer (PFE), Merck & Co. (MRK), Bristol Myers Squibb (BMY), Regeneron Pharmaceuticals (REGN) and Moderna (MRNA). This peer set is drawn from ABBV's enriched company profile and is informational only — not financial advice.
Similar companies
-
Johnson & JohnsonJNJHealth Care
A global healthcare leader spanning pharmaceuticals, medical devices, and consumer health products, with a portfolio spanning acute care, oncology, immunology,…
$249.97 (as of 2026-07-16) · market cap $599.2B
-
AmgenAMGNHealth Care
A global biotechnology innovator producing biologics, monoclonal antibodies, and small molecules across oncology, cardiovascular, inflammation, and bone…
$371.58 (as of 2026-07-16) · market cap $196.8B
-
Lilly (Eli)LLYHealth Care
A global pharmaceutical powerhouse developing innovative medicines across cardiometabolic, oncology, and immunology with blockbuster GLP-1 and weight-loss…
$1,169.17 (as of 2026-07-16) · market cap $1.09T
-
PfizerPFEHealth Care
Global biopharmaceutical company discovering, developing, and manufacturing prescription medicines and vaccines across oncology, immunology, cardiovascular,…
$25.14 (as of 2026-07-16) · market cap $143.1B
-
Merck & Co.MRKHealth Care
Global pharmaceutical and vaccine leader with oncology, infectious disease, and animal health franchises, anchored by blockbuster immunotherapy Keytruda.
$127.63 (as of 2026-07-16) · market cap $311.9B
-
Bristol Myers SquibbBMYHealth Care
A diversified biopharmaceutical company leveraging immunotherapy, cell therapies, and small-molecule platforms to address cancer, autoimmune disease, and…
$60.51 (as of 2026-07-16) · market cap $121.8B
-
Regeneron PharmaceuticalsREGNHealth Care
Regeneron develops and commercializes monoclonal antibody and other biologics therapies across immunology, oncology, infectious disease, and other therapeutic…
$678.94 (as of 2026-07-16) · market cap $70.5B
-
ModernaMRNAHealth Care
Moderna is an unprofitable mRNA vaccine and therapeutic company pivoting from peak COVID revenues with a diversified pipeline facing intense competition and…
$63.15 (as of 2026-07-16) · market cap $25.1B
Not quite? Describe exactly what you want →
Peers are drawn from ABBV's enriched profile (the same similarity signal the chat uses for "companies like ABBV"). See the full profile: AbbVie (ABBV).
Last updated 2026-07-16.
Informational only — NOT financial advice. Company data is sourced from SEC EDGAR + Finnhub and shown with its as-of date.